{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:24:25Z","timestamp":1778826265110,"version":"3.51.4"},"reference-count":54,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Lower Anogenital Squamous Terminology (LAST) standardization recommended p16INK4a immunohistochemistry (p16 IHC) for biopsies diagnosed morphologically as cervical intraepithelial neoplasia (CIN) grade 2 (CIN2) to classify them as low-grade or high-grade squamous intraepithelial lesions (HSILs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To describe the relationships of p16 IHC and other biomarkers associated with cervical cancer risk with biopsy diagnoses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>A statewide, stratified sample of cervical biopsies diagnosed by community pathologists (CPs), including 1512 CIN2, underwent a consensus, expert pathologist panel (EP) review (without p16 IHC results), p16 IHC interpretation by a third pathology group, and human papillomavirus (HPV) genotyping, results of which were grouped hierarchically according to cancer risk. Antecedent cytologic interpretations were also available.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>Biopsies were more likely to test p16 IHC positive with increasing severity of CP diagnoses, overall (Ptrend \u2264 .001) and within each HPV risk group (Ptrend \u2264 .001 except for low-risk HPV [Ptrend &amp;lt; .010]). All abnormal grades of CP-diagnosed biopsies were more likely to test p16 IHC positive with a higher HPV risk group (Ptrend &amp;lt; .001), and testing p16 IHC positive was associated with higher HPV risk group than testing p16 IHC negative for each grade of CP-diagnosed biopsies (P &amp;lt; .001). p16 IHC\u2013positive, CP-diagnosed CIN2 biopsies were less likely than CP-diagnosed CIN3 biopsies to test HPV16 positive, have an antecedent HSIL+ cytology, or to be diagnosed as CIN3+ by the EP (P &amp;lt; .001 for all). p16 IHC\u2013positive, CP-diagnosed CIN1 biopsies had lower HPV risk groups than p16 IHC\u2013negative, CP-diagnosed CIN2 biopsies (P &amp;lt; .001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>p16 IHC\u2013positive, CP-diagnosed CIN2 appears to be lower cancer risk than CP-diagnosed CIN3. LAST classification of \u201cHSIL\u201d diagnosis, which includes p16 IHC\u2013positive CIN2, should annotate the morphologic diagnosis (CIN2 or CIN3) to inform all management decisions, which is especially important for young (&amp;lt;30 years) women diagnosed with CIN2 for whom surveillance rather than treatment is recommended.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2019-0241-oa","type":"journal-article","created":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T10:21:37Z","timestamp":1573640497000},"page":"725-734","source":"Crossref","is-referenced-by-count":35,"title":["Relationships of p16 Immunohistochemistry and Other Biomarkers With Diagnoses of Cervical Abnormalities: Implications for LAST Terminology"],"prefix":"10.5858","volume":"144","author":[{"given":"Philip E.","family":"Castle","sequence":"first","affiliation":[{"name":"From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Departm"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael","family":"Adcock","sequence":"additional","affiliation":[{"name":"From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Departm"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Cuzick","sequence":"additional","affiliation":[{"name":"From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Departm"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Wentzensen","sequence":"additional","affiliation":[{"name":"From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Departm"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norah E.","family":"Torrez-Martinez","sequence":"additional","affiliation":[{"name":"From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Departm"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salina M.","family":"Torres","sequence":"additional","affiliation":[{"name":"From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Departm"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark H.","family":"Stoler","sequence":"additional","affiliation":[{"name":"From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Departm"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte M.","family":"Ronnett","sequence":"additional","affiliation":[{"name":"From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Departm"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy E.","family":"Joste","sequence":"additional","affiliation":[{"name":"From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Departm"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa M.","family":"Darragh","sequence":"additional","affiliation":[{"name":"From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Departm"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patti E.","family":"Gravitt","sequence":"additional","affiliation":[{"name":"From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Departm"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[{"name":"From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Departm"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C.","family":"Hunt","sequence":"additional","affiliation":[{"name":"From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Departm"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter K.","family":"Kinney","sequence":"additional","affiliation":[{"name":"From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Departm"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cosette M.","family":"Wheeler","sequence":"additional","affiliation":[{"name":"From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Departm"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"New Mexico HPV Pap Registry Steering Committee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"p16 IHC Study Panel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","published-online":{"date-parts":[[2019,11,13]]},"reference":[{"issue":"1","key":"2020081300350947400_i1543-2165-144-6-725-b01","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"issue":"11","key":"2020081300350947400_i1543-2165-144-6-725-b02","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"issue":"10","key":"2020081300350947400_i1543-2165-144-6-725-b03","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/ijc.27485","article-title":"Human papillomavirus types in 115, 789 HPV-positive women: a meta-analysis from cervical infection to cancer","volume":"131","author":"Guan","year":"2012","journal-title":"Int J Cancer"},{"issue":"5 suppl 1","key":"2020081300350947400_i1543-2165-144-6-725-b04","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/LGT.0b013e318287d329","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"17","author":"Massad","year":"2013","journal-title":"J Low Genit Tract Dis"},{"issue":"9590","key":"2020081300350947400_i1543-2165-144-6-725-b05","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"issue":"7 pt 2","key":"2020081300350947400_i1543-2165-144-6-725-b06","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/00006254-196907001-00017","article-title":"A theory of cervical carcinogenesis","volume":"24","author":"Richart","year":"1969","journal-title":"Obstet Gynecol Surv"},{"issue":"11","key":"2020081300350947400_i1543-2165-144-6-725-b07","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/jclinpath-2018-205271","article-title":"Three-tiered score for Ki-67 and p16(ink4a) improves accuracy and reproducibility of grading CIN lesions","volume":"71","author":"van Zummeren","year":"2018","journal-title":"J Clin Pathol"},{"issue":"11","key":"2020081300350947400_i1543-2165-144-6-725-b08","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.285.11.1500","article-title":"Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study","volume":"285","author":"Stoler","year":"2001","journal-title":"JAMA"},{"issue":"4","key":"2020081300350947400_i1543-2165-144-6-725-b09","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/pgp.0b013e31805152ab","article-title":"CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples","volume":"26","author":"Carreon","year":"2007","journal-title":"Int J Gynecol Pathol"},{"issue":"6","key":"2020081300350947400_i1543-2165-144-6-725-b10","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/PAS.0000000000000381","article-title":"The interpretive variability of cervical biopsies and its relationship to HPV status","volume":"39","author":"Stoler","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"2020081300350947400_i1543-2165-144-6-725-b11","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1309\/AJCP3TPHV4TRIZEK","article-title":"p16INK4a immunohistochemistry in cervical biopsy specimens: a systematic review and meta-analysis of the interobserver agreement","volume":"142","author":"Reuschenbach","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"2020081300350947400_i1543-2165-144-6-725-b12","doi-asserted-by":"crossref","first-page":"k499","DOI":"10.1136\/bmj.k499","article-title":"Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis","volume":"360","author":"Tainio","year":"2018","journal-title":"BMJ"},{"issue":"9","key":"2020081300350947400_i1543-2165-144-6-725-b13","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/1471-0528.13839","article-title":"Risk of preterm birth following surgical treatment for cervical disease: executive summary of a recent symposium","volume":"123","author":"Sasieni","year":"2016","journal-title":"BJOG"},{"key":"2020081300350947400_i1543-2165-144-6-725-b14","article-title":"Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis","volume":"354","author":"Kyrgiou","year":"2016","journal-title":"BMJ"},{"issue":"1","key":"2020081300350947400_i1543-2165-144-6-725-b15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1309\/A8MFC18TWANC8QFH","article-title":"Can HPV-16 genotyping provide a benchmark for cervical biopsy specimen interpretation?","volume":"130","author":"Galgano","year":"2008","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"2020081300350947400_i1543-2165-144-6-725-b16","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/PAS.0b013e3181e8b2c4","article-title":"Using biomarkers as objective standards in the diagnosis of cervical biopsies","volume":"34","author":"Galgano","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"2020081300350947400_i1543-2165-144-6-725-b17","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/modpathol.2012.156","article-title":"Immunohistochemical detection of human papillomavirus capsid proteins L1 and L2 in squamous intraepithelial lesions: potential utility in diagnosis and management","volume":"26","author":"Yemelyanova","year":"2013","journal-title":"Mod Pathol"},{"issue":"7","key":"2020081300350947400_i1543-2165-144-6-725-b18","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/modpathol.2015.52","article-title":"Stratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in combination with p16 or MCM","volume":"28","author":"Griffin","year":"2015","journal-title":"Mod Pathol"},{"issue":"11","key":"2020081300350947400_i1543-2165-144-6-725-b19","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1097\/PAS.0000000000000498","article-title":"Investigating diagnostic problems of CIN1 and CIN2 associated with high-risk HPV by combining the novel molecular biomarker PanHPVE4 with p16INK4a","volume":"39","author":"van Baars","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"2020081300350947400_i1543-2165-144-6-725-b20","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00000478-200211000-00001","article-title":"p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia","volume":"26","author":"Klaes","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"2020081300350947400_i1543-2165-144-6-725-b21","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/PAS.0000000000001072","article-title":"Routine use of adjunctive p16 immunohistochemistry improves diagnostic agreement of cervical biopsy interpretation: Results from the CERTAIN study","volume":"42","author":"Stoler","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"2020081300350947400_i1543-2165-144-6-725-b22","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.5858\/arpa.LGT200570","article-title":"The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology","volume":"136","author":"Darragh","year":"2012","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"2020081300350947400_i1543-2165-144-6-725-b23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol"},{"issue":"2","key":"2020081300350947400_i1543-2165-144-6-725-b24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/aje\/kwp390","article-title":"Impact of improved classification on the association of human papillomavirus with cervical precancer","volume":"171","author":"Castle","year":"2010","journal-title":"Am J Epidemiol"},{"issue":"5","key":"2020081300350947400_i1543-2165-144-6-725-b25","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1309\/PT3PNC1QL2F4D2VL","article-title":"The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report","volume":"127","author":"Castle","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"2020081300350947400_i1543-2165-144-6-725-b26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ijc.27680","article-title":"Incidence risk of cervical intraepithelial neoplasia 3 or more severe lesions is a function of human papillomavirus genotypes and severity of cytological and histological abnormalities in adult Japanese women","volume":"132","author":"Hosaka","year":"2013","journal-title":"Int J Cancer"},{"issue":"3","key":"2020081300350947400_i1543-2165-144-6-725-b27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1158\/1940-6207.CAPR-17-0293","article-title":"Clinical outcomes after conservative management of cervical intraepithelial neoplasia grade 2 (CIN2) in women ages 21-39 years","volume":"11","author":"Silver","year":"2018","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"2020081300350947400_i1543-2165-144-6-725-b28","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1158\/1055-9965.EPI-14-0775","article-title":"Human papillomavirus genotype-specific prevalence across the continuum of cervical neoplasia and cancer","volume":"24","author":"Joste","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"2020081300350947400_i1543-2165-144-6-725-b29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/JCM.38.1.357-361.2000","article-title":"Improved amplification of genital human papillomaviruses","volume":"38","author":"Gravitt","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"11","key":"2020081300350947400_i1543-2165-144-6-725-b30","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1086\/320696","article-title":"Determinants of genital human papillomavirus detection in a US population","volume":"183","author":"Peyton","year":"2001","journal-title":"J Infect Dis"},{"issue":"5","key":"2020081300350947400_i1543-2165-144-6-725-b31","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1158\/1055-9965.EPI-07-2904","article-title":"A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study","volume":"17","author":"Gravitt","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"2020081300350947400_i1543-2165-144-6-725-b32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ijc.27608","article-title":"A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination","volume":"132","author":"Wheeler","year":"2013","journal-title":"Int J Cancer"},{"issue":"6","key":"2020081300350947400_i1543-2165-144-6-725-b33","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Munoz","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"2020081300350947400_i1543-2165-144-6-725-b34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/sim.4780040112","article-title":"A Wilcoxon-type test for trend","volume":"4","author":"Cuzick","year":"1985","journal-title":"Stat Med"},{"issue":"16","key":"2020081300350947400_i1543-2165-144-6-725-b35","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"issue":"7","key":"2020081300350947400_i1543-2165-144-6-725-b36","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn510","article-title":"Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States","volume":"101","author":"Wheeler","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"2020081300350947400_i1543-2165-144-6-725-b37","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1158\/0008-5472.CAN-08-4192","article-title":"Detection of precancerous cervical lesions is differential by human papillomavirus type","volume":"69","author":"Safaeian","year":"2009","journal-title":"Cancer Res"},{"issue":"3","key":"2020081300350947400_i1543-2165-144-6-725-b38","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/LGT.0000000000000181","article-title":"p16 immunohistochemistry in colposcope-directed and random cervical biopsies of CIN2 and CIN3","volume":"20","author":"Arvizo","year":"2016","journal-title":"J Low Genit Tract Dis"},{"issue":"2","key":"2020081300350947400_i1543-2165-144-6-725-b39","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/modpathol.2016.168","article-title":"Usefulness of p16(INK4a) staining for managing histological high-grade squamous intraepithelial cervical lesions","volume":"30","author":"Miralpeix","year":"2017","journal-title":"Mod Pathol"},{"issue":"1","key":"2020081300350947400_i1543-2165-144-6-725-b40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijgo.2015.12.005","article-title":"The association between p16 and Ki-67 immunohistostaining and the progression of cervical intraepithelial neoplasia grade 2","volume":"134","author":"Miyamoto","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"2020081300350947400_i1543-2165-144-6-725-b41","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/PAS.0000000000000747","article-title":"CK7 immunohistochemistry as a predictor of CIN1 progression: a retrospective study of patients from the quadrivalent HPV vaccine trials","volume":"41","author":"Mills","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2020081300350947400_i1543-2165-144-6-725-b42","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/ijc.28407","article-title":"Prognostic value of p16-INK4A protein in women with negative or CIN1 histology result: a follow-up study","volume":"134","author":"Pacchiarotti","year":"2014","journal-title":"Int J Cancer"},{"issue":"1","key":"2020081300350947400_i1543-2165-144-6-725-b43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/modpathol.2015.126","article-title":"p16 staining has limited value in predicting the outcome of histological low-grade squamous intraepithelial lesions of the cervix","volume":"29","author":"Sagasta","year":"2016","journal-title":"Mod Pathol"},{"issue":"1","key":"2020081300350947400_i1543-2165-144-6-725-b44","doi-asserted-by":"crossref","first-page":"76","DOI":"10.5858\/arpa.2012-0472-OA","article-title":"Variability of pathologists' utilization of p16 and ki-67 immunostaining in the diagnosis of cervical biopsies in routine pathology practice and its impact on the frequencies of cervical intraepithelial neoplasia diagnoses and cytohistologic correlations","volume":"138","author":"Singh","year":"2014","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"2020081300350947400_i1543-2165-144-6-725-b45","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/ajcp\/102.2.182","article-title":"Toward objective quality assurance in cervical cytopathology: correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types","volume":"102","author":"Sherman","year":"1994","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"2020081300350947400_i1543-2165-144-6-725-b46","first-page":"2979","article-title":"P16 and Ki-67 expression improves the diagnostic accuracy of cervical lesions but not predict persistent high risk human papillomavirus infection with CIN1","volume":"8","author":"Zhong","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"2020081300350947400_i1543-2165-144-6-725-b47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/1066896913496147","article-title":"Role of p16, CK17, p63, and human papillomavirus in diagnosis of cervical intraepithelial neoplasia and distinction from its mimics","volume":"22","author":"Selvi","year":"2014","journal-title":"Int J Surg Pathol"},{"issue":"2","key":"2020081300350947400_i1543-2165-144-6-725-b48","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/1066896911427703","article-title":"Utility of p16, Ki-67, and HPV test in diagnosis of cervical intraepithelial neoplasia and atrophy in women older than 50 years with 3- to 7-year follow-up","volume":"20","author":"Jackson","year":"2012","journal-title":"Int J Surg Pathol"},{"issue":"2","key":"2020081300350947400_i1543-2165-144-6-725-b49","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1309\/AJCP1LLX8QMDXHHO","article-title":"Efficacy of p16 and ProExC immunostaining in the detection of high-grade cervical intraepithelial neoplasia and cervical carcinoma","volume":"135","author":"Guo","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"2020081300350947400_i1543-2165-144-6-725-b50","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1309\/AJCPBX74QXCPXIKK","article-title":"Assessment of correlation between p16INK4a staining, specific subtype of human papillomavirus, and progression of LSIL\/CIN1 lesions: first comparative study","volume":"142","author":"Razmpoosh","year":"2014","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"2020081300350947400_i1543-2165-144-6-725-b51","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/AOG.0000000000002812","article-title":"Risk of cervical intraepithelial neoplasia 2 or worse by cytology, human papillomavirus 16\/18, and colposcopy impression: a systematic review and meta-analysis","volume":"132","author":"Silver","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"12","key":"2020081300350947400_i1543-2165-144-6-725-b52","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1158\/1055-9965.EPI-16-0330","article-title":"Cervical precancer and cancer risk by human papillomavirus status and cytologic interpretation: implications for risk-based management","volume":"25","author":"Castle","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"2020081300350947400_i1543-2165-144-6-725-b53","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1586\/epr.12.13","article-title":"Biomarkers for cervical cancer screening: the role of p16(INK4a) to highlight transforming HPV infections","volume":"9","author":"von Knebel","year":"2012","journal-title":"Expert Rev Proteomics"},{"issue":"9","key":"2020081300350947400_i1543-2165-144-6-725-b54","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2217\/fmb.11.87","article-title":"Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts","volume":"6","author":"Sahasrabuddhe","year":"2011","journal-title":"Future Microbiol"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/144\/6\/725\/2521640\/arpa_2019-0241-oa.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/144\/6\/725\/2521640\/arpa_2019-0241-oa.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:40:18Z","timestamp":1764790818000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/144\/6\/article-p725.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,13]]},"references-count":54,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,11,13]]},"published-print":{"date-parts":[[2020,6,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2019-0241-oa","relation":{},"ISSN":["0003-9985","1543-2165"],"issn-type":[{"value":"0003-9985","type":"print"},{"value":"1543-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,13]]}}}